arrow
J

Joachim Burman

uppsala university
H指数:36
被引数:5,565

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Late complications after autologous HSCT for autoimmune diseases: a retrospective survey from the autoimmune diseases working party (ADWP), transplant complications working party (TCWP) and paediatric diseases working party (PDWP) of the european society for blood and marrow transplantation (EBMT)

自体造血干细胞移植治疗自身免疫性疾病的晚期并发症:欧洲血液与骨髓移植学会(EBMT)自身免疫性疾病工作组(ADWP)、移植并发症工作组(TCWP)和儿科疾病工作组(PDWP)的回顾性调查

2026-07-270
PRE
Dimethyl Fumarate, But Not Rituximab, Reduces Serum GFAP Levels and PIRMA in Relapsing–Remitting MS

富马酸二甲酯,而非利妥昔单抗,可降低复发-缓解型多发性硬化患者血清中胶质原纤维酸性蛋白水平及PIRMA

2026-04-120
OA
Co-exposure to PFAS and hydroxylated PCBs is associated with increased odds of multiple sclerosis

同时接触PFAS和羟基PCBs与多发性硬化症发病风险的增加相关。

2025-12-110
OAAI
The MMP-9/TIMP-1 Ratio and Concentrations of Osteopontin Are Elevated in Cerebrospinal Fluid of People With Multiple Sclerosis and Decrease After Autologous Hematopoietic Stem Cell Transplantation

MMP-9/TIMP-1比率及骨桥蛋白浓度在多发性硬化患者脑脊液中升高,并在自体造血干细胞移植后降低。

2025-10-140
OAAI
BEAM/ATG or cyclophosphamide/ATG as conditioning regimen in autologous haemopoietic stem cell transplantation for multiple sclerosis: a retrospective analysis of the EBMT autoimmune diseases working party

BEAM/ATG 或环磷酰胺/ATG 作为自体造血干细胞移植治疗多发性硬化中的预处理方案:EBMT 自身免疫性疾病工作组的一项回顾性分析

2025-09-290
OAAI
Haematopoietic stem cell transplant versus immune-reconstitution therapy in relapsing multiple sclerosis

造血干细胞移植与免疫重建疗法在复发型多发性硬化中的比较

Brain
IF11.7
2025-08-040
PRE
Neuroglial Biomarkers for Risk Assessment of Ischemic Stroke and Other Cardiovascular Events in Patients With Atrial Fibrillation Not Receiving Oral Anticoagulation

神经胶质生物标志物在未接受口服抗凝治疗的房颤患者缺血性卒中和其他心血管事件风险评估中的应用

2025-01-210
PRE